Literature DB >> 10837532

Review of dry powder inhalers.

.   

Abstract

The search for alternatives to metered-dose inhalers has accelerated recently in a bid to find effective products that do not use chlorofluorocarbon (CFC) propellants. This paper reviews the factors to be considered in developing dry powder inhalers (DPIs), particularly the formulation, metering design and flow path in the device. The advantages and disadvantages of current DPIs are discussed and possible future approaches outlined.

Entities:  

Year:  1997        PMID: 10837532     DOI: 10.1016/s0169-409x(97)00510-3

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  19 in total

1.  Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers.

Authors:  V Chavan; R Dalby
Journal:  AAPS PharmSci       Date:  2000

Review 2.  Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.

Authors:  Timothy M Crowder; Jacky A Rosati; Jeffry D Schroeter; Anthony J Hickey; Ted B Martonen
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

3.  Measuring surface roughness of pharmaceutical powders using vapor sorption methods.

Authors:  Daniel J Burnett; Jerry Y Y Heng; Frank Thielmann; Armando R Garcia; Majid Naderi; Manaswini Acharya
Journal:  AAPS PharmSciTech       Date:  2010-12-18       Impact factor: 3.246

4.  Characterization of drug particle surface energetics and young's modulus by atomic force microscopy and inverse gas chromatography.

Authors:  Michael Davies; Anne Brindley; Xinyong Chen; Maria Marlow; Stephen W Doughty; Ian Shrubb; Clive J Roberts
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

5.  Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler.

Authors:  Matthew S Coates; Hak-Kim Chan; David F Fletcher; Herbert Chiou
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

Review 6.  Lactose engineering for better performance in dry powder inhalers.

Authors:  Yahya Rahimpour; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2012-08-15

7.  Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil.

Authors:  Thi-Tram Nguyen; Eun-Jin Yi; Kyu-Mok Hwang; Cheol-Hee Cho; Chun-Woong Park; Ju-Young Kim; Yun-Seok Rhee; Eun-Seok Park
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

8.  Influence of fluoxetine on olanzapine pharmacokinetics.

Authors:  Denis Gossen; Jean-Marie de Suray; Francois Vandenhende; Claude Onkelinx; Diamon Gangji
Journal:  AAPS PharmSci       Date:  2002

9.  Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

Authors:  Yoen-Ju Son; P Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2013-01-10       Impact factor: 5.875

10.  Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation.

Authors:  Yoen-Ju Son; P Worth Longest; Geng Tian; Michael Hindle
Journal:  Eur J Pharm Sci       Date:  2013-04-19       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.